GE, Veran align for interventional oncology technologies
GE Healthcare and Veran Medical Technologies have entered into a strategic alliance to co-develop navigation technologies for interventional procedures to improve the care and management of cancer patients.
Building on the alliance, the GE’s Healthymagination Fund, an equity fund that makes investments in healthcare technology companies, is investing in Veran. The financial terms were undisclosed.
Veran manufactures the ig4 navigation system which integrates multimodality information at the point of patient care in the interventional suite and combines that information with electromagnetic tracking of instruments with imbedded sensors. The ig4 system aims to provide guidance to interventional clinicians when they are steering an instrument inside the human body to perform an oncologic intervention such as cancer biopsy and ablation.
Earlier this year, GE became the exclusive distributor and reseller of Veran’s ig4 Navigation system in the U.S. The ig4 navigation system is compatible with GE’s Innova imaging systems, which acquire images of the target organ(s) that can be exported to the navigation system in the same imaging suite, during the same interventional procedure. The resulting displayed image provides navigation information to help physicians insert biopsy needles, ablation (radiofrequency, cryotherapy and microwave) probes and other devices through the skin.
Building on the alliance, the GE’s Healthymagination Fund, an equity fund that makes investments in healthcare technology companies, is investing in Veran. The financial terms were undisclosed.
Veran manufactures the ig4 navigation system which integrates multimodality information at the point of patient care in the interventional suite and combines that information with electromagnetic tracking of instruments with imbedded sensors. The ig4 system aims to provide guidance to interventional clinicians when they are steering an instrument inside the human body to perform an oncologic intervention such as cancer biopsy and ablation.
Earlier this year, GE became the exclusive distributor and reseller of Veran’s ig4 Navigation system in the U.S. The ig4 navigation system is compatible with GE’s Innova imaging systems, which acquire images of the target organ(s) that can be exported to the navigation system in the same imaging suite, during the same interventional procedure. The resulting displayed image provides navigation information to help physicians insert biopsy needles, ablation (radiofrequency, cryotherapy and microwave) probes and other devices through the skin.